News & Events Year Any 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 Date Title Format Feb 17, 2026 Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board PDF Version Jan 05, 2026 Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression PDF Version
